These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 34833096)

  • 21. Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease.
    Scucchi L; Neri B; Sarmati L; Mossa M; Sena G; Massoud R; Petruzziello C; Musumeci M; Marafini I; Calabrese E; Lolli E; Bernardini S; Andreoni M; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2418-2424. PubMed ID: 33755981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.
    Chebli JMF; Queiroz NSF; Damião AOMC; Chebli LA; Costa MHM; Parra RS
    World J Gastroenterol; 2021 Mar; 27(11):1022-1042. PubMed ID: 33776370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
    Weaver KN; Kappelman MD; Long MD
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):388-399. PubMed ID: 36397773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to Face the Advent of SARS-CoV-2 Vaccination in IBD Patients: Another Task for Gastroenterologists.
    Papa A; Scaldaferri F; Vetrone LM; Neri M; Gasbarrini A; Lopetuso LR
    Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33808983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of remission with tacrolimus in a patient with severe acute, cortisone refractory ulcerative colitis and severe Covid-19 pneumonia: a case report.
    Rieker L; Hofer J; Petzold G; Ellenrieder V; Amanzada A
    BMC Gastroenterol; 2022 Jan; 22(1):22. PubMed ID: 35033015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases.
    Pokryszka J; Wagner A; Wiedermann U; Tobudic S; Herkner H; Winkler S; Brehovsky S; Reinisch W; Novacek G
    Vaccines (Basel); 2022 May; 10(5):. PubMed ID: 35632515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review on medical management of inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Chela H; Pasha SB; Wan XF; Ghouri YA
    J Gastroenterol Hepatol; 2021 Apr; 36(4):918-926. PubMed ID: 32876952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Biologics on SARS-COV-2 Disease Course When Infused Within 2 Weeks of Acquiring the Infection Among IBD Patients.
    Khan N; Patel M; Sundararajan R
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):232-233. PubMed ID: 36029967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two Case Reports of Newly Diagnosed Crohn's Disease after COVID-19 in Pediatric Patients.
    Kim K; Kim SY; Kim YE; Kwon KW; Han EM; Kim A
    Korean J Gastroenterol; 2023 Apr; 81(4):163-167. PubMed ID: 37096436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.
    Mastrangeli G; Vernia F; Necozione S; Muselli M; Frassino S; Cesaro N; Latella G; Fabiani L
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crohn's and Colitis Canada's 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy.
    Kaplan GG; Windsor JW; Crain J; Barrett L; Bernstein CN; Bitton A; Chauhan U; Coward S; Fowler S; Ghia JE; Gibson DL; Griffiths AM; Jones JL; Khanna R; Kuenzig ME; Lakatos PL; Lee K; Mack DR; Marshall JK; Mawani M; Murthy SK; Panaccione R; Seow CH; Targownik LE; Zelinsky S; Benchimol EI
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S10-S19. PubMed ID: 34755034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addendum to S3-Guidelines Crohn's disease and ulcerative colitis: Management of Patients with Inflammatory Bowel Disease in the COVID-19 Pandemic - open questions and answers.
    Stallmach A; Sturm A; Blumenstein I; Helwig U; Koletzko S; Lynen P; Schmidt C; Dignass A; Kucharzik T;
    Z Gastroenterol; 2020 Oct; 58(10):982-1002. PubMed ID: 33036052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of severe acute ulcerative colitis in SARS-CoV-2 infected patients: report of three cases and discussion of treatment options.
    Bourgonje AR; van Linschoten RCA; West RL; van Dijk MA; van Leer-Buter CC; Kats-Ugurlu G; Pierik MJ; Festen EAM; Weersma RK; Dijkstra G
    Therap Adv Gastroenterol; 2021; 14():17562848211012595. PubMed ID: 33995584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
    United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.
    Di Ruscio M; Lunardi G; Buonfrate D; Gobbi F; Bertoli G; Piccoli D; Conti A; Geccherle A; Variola A
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684085
    [No Abstract]   [Full Text] [Related]  

  • 38. Common contributing factors to COVID-19 and inflammatory bowel disease.
    Kostoff RN; Briggs MB; Kanduc D; Shores DR; Kovatsi L; Vardavas AI; Porter AL
    Toxicol Rep; 2021; 8():1616-1637. PubMed ID: 34485092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System.
    Khan N; Mahmud N; Trivedi C; Reinisch W; Lewis JD
    Gut; 2021 Sep; 70(9):1657-1664. PubMed ID: 33753416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD.
    Bernstein CN; Singh H; Murthy SK; Nguyen GC; Benchimol EI; Bitton A; Kuenzig ME; Huang JG; Jones JL; Lee K; Targownik LE; Windsor JW; Mukhtar MS; Tandon P; Kaplan GG
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S34-S39. PubMed ID: 34755037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.